Low manufacturing and R&D costs, coupled with government incentives for generic drugs (off-patent) as against higher priced branded drugs in India and China is expected to force most pharmaceutical companies to shift their focus to manufacturing in these two...
Asian currencies, oil, gold and stock markets all rose on positive manufacturing numbers from Asia and America yesterday. Signaling a bouncing back of the economy of sorts, the splurge in holiday shopping, and lower unemployment numbers, raised China’s PMI to...
The beginning of December, the last month of accounting year 2010 always marks financial consolidation in China – furtive spending by Chinese provincial governments eager to dispense their budgets before the year end and tax collection by the central government....
